These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 10881004)

  • 1. Proton magnetic resonance spectroscopy ((1)H-MRS) of the brain following high-dose methotrexate treatment for childhood cancer.
    Davidson A; Payne G; Leach MO; McVicar D; Britton JM; Watson M; Tait DM
    Med Pediatr Oncol; 2000 Jul; 35(1):28-34. PubMed ID: 10881004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term cerebral metabolite changes on proton magnetic resonance spectroscopy in patients cured of acute lymphoblastic leukemia with previous intrathecal methotrexate and cranial irradiation prophylaxis.
    Chan YL; Roebuck DJ; Yuen MP; Yeung KW; Lau KY; Li CK; Chik KW
    Int J Radiat Oncol Biol Phys; 2001 Jul; 50(3):759-63. PubMed ID: 11395245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the late effects of CNS prophylactic treatment in childhood acute lymphoblastic leukemia (ALL) using magnetic resonance spectroscopy.
    Ficek K; Blamek S; Syguła D; Miszczyk L; Sońta-Jakimczyk D; Tarnawski R
    Acta Neurochir Suppl; 2010; 106():195-7. PubMed ID: 19812948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Detection of subclinical and overt hepatic encephalopathy and treatment control after L-ornithine-L-aspartate medication by magnetic resonance spectroscopy ((1)H-MRS)].
    Hass HG; Nägele T; Seeger U; Hösl F; Gregor M; Kaiser S
    Z Gastroenterol; 2005 Apr; 43(4):373-8. PubMed ID: 15830303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-leukemic treatment-induced neurotoxicity in long-term survivors of childhood acute lymphoblastic leukemia: impact of reduced central nervous system radiotherapy and intermediate- to high-dose methotrexate.
    Zając-Spychała O; Pawlak M; Karmelita-Katulska K; Pilarczyk J; Jończyk-Potoczna K; Przepióra A; Derwich K; Wachowiak J
    Leuk Lymphoma; 2018 Oct; 59(10):2342-2351. PubMed ID: 29424258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Magnetic resonance imaging and spectroscopy of regional brain structure in a 10-year-old boy with elevated blood lead levels.
    Trope I; Lopez-Villegas D; Lenkinski RE
    Pediatrics; 1998 Jun; 101(6):E7. PubMed ID: 9606249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Late sequelae of CNS recurrence of acute lymphoblastic leukemia in childhood].
    Steinberg S; Hartmann R; Wisniewski S; Berger K; Beck JD; Henze G
    Klin Padiatr; 1998; 210(4):200-6. PubMed ID: 9743953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of early cerebral metabolic, perfusion and microstructural changes in HCV-positive patients: a pilot study.
    Bladowska J; Zimny A; Knysz B; Małyszczak K; Kołtowska A; Szewczyk P; Gąsiorowski J; Furdal M; Sąsiadek MJ
    J Hepatol; 2013 Oct; 59(4):651-7. PubMed ID: 23680314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Magnetic resonance spectroscopy in the evaluation of neurotoxicity following cranial irradiation for childhood cancer.
    Davidson A; Tait DM; Payne GS; Hopewell JW; Leach MO; Watson M; MacVicar AD; Britton JA; Ashley S
    Br J Radiol; 2000 Apr; 73(868):421-4. PubMed ID: 10844868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. White matter changes on MRI during treatment in children with acute lymphoblastic leukemia: correlation with neuropsychological findings.
    Pääkkö E; Harila-Saari A; Vanionpää L; Himanen S; Pyhtinen J; Lanning M
    Med Pediatr Oncol; 2000 Nov; 35(5):456-61. PubMed ID: 11070477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence of reversible axonal dysfunction in systemic lupus erythematosus: a proton MRS study.
    Appenzeller S; Li LM; Costallat LT; Cendes F
    Brain; 2005 Dec; 128(Pt 12):2933-40. PubMed ID: 16195241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Late magnetic resonance imaging features of leukoencephalopathy in children with central nervous system tumours following high-dose methotrexate and neuraxis radiation therapy.
    Kellie SJ; Chaku J; Lockwood LR; O'Regan P; Waters KD; Wong CK;
    Eur J Cancer; 2005 Jul; 41(11):1588-96. PubMed ID: 16026694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. White matter and cerebral metabolite changes in children undergoing treatment for acute lymphoblastic leukemia: longitudinal study with MR imaging and 1H MR spectroscopy.
    Chu WC; Chik KW; Chan YL; Yeung DK; Roebuck DJ; Howard RG; Li CK; Metreweli C
    Radiology; 2003 Dec; 229(3):659-69. PubMed ID: 14576448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term cognitive outcome, brain computed tomography scan, and magnetic resonance imaging in children cured for acute lymphoblastic leukemia.
    Iuvone L; Mariotti P; Colosimo C; Guzzetta F; Ruggiero A; Riccardi R
    Cancer; 2002 Dec; 95(12):2562-70. PubMed ID: 12467071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cognitive performance and magnetic resonance imaging findings after high-dose systemic and intraventricular chemotherapy for primary central nervous system lymphoma.
    Fliessbach K; Urbach H; Helmstaedter C; Pels H; Glasmacher A; Kraus JA; Klockgether T; Schmidt-Wolf I; Schlegel U
    Arch Neurol; 2003 Apr; 60(4):563-8. PubMed ID: 12707070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brain perfusion after treatment of childhood acute lymphoblastic leukemia.
    Harila-Saari AH; Ahonen AK; Vainionpää LK; Pääkkö EL; Pyhtinen J; Himanen AS; Torniainen PJ; Lanning BM
    J Nucl Med; 1997 Jan; 38(1):82-8. PubMed ID: 8998157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered white matter metabolism in delayed neurologic sequelae after carbon monoxide poisoning: A proton magnetic resonance spectroscopic study.
    Kuroda H; Fujihara K; Mugikura S; Takahashi S; Kushimoto S; Aoki M
    J Neurol Sci; 2016 Jan; 360():161-9. PubMed ID: 26723994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proton magnetic resonance spectroscopy in immunocompetent patients with primary central nervous system lymphoma.
    Raizer JJ; Koutcher JA; Abrey LE; Panageas KS; DeAngelis LM; Lis E; Xu S; Zakian KL
    J Neurooncol; 2005 Jan; 71(2):173-80. PubMed ID: 15690135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brain magnetic resonance spectroscopy (MRS) as a diagnostic tool for detecting early neurological changes in children with Wilson's disease.
    Alkhalik Basha MA; Refaat R; Ahmed AF; Yousef HY; Alsowey AM; Metwally MI; Aly SA; Hussien HM; El-Saadany HF; AlGhobashy AA; Talat MA; Amer MM; Eid AM
    Eur J Radiol; 2019 Feb; 111():41-46. PubMed ID: 30691663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Magnetic resonance imaging and neurological evaluation after treatment with high-dose methotrexate for acute lymphocytic leukaemia in young children.
    Seidel H; Nygaard R; Haave I; Moe PJ
    Acta Paediatr; 1996 Apr; 85(4):450-3. PubMed ID: 8740303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.